Vanguard Group Inc Pds Biotechnology Corp Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Vanguard Group Inc holds 1,510,221 shares of PDSB stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,510,221
Previous 1,505,812
0.29%
Holding current value
$1.74 Million
Previous $2.45 Million
26.77%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding PDSB
# of Institutions
54Shares Held
8.23MCall Options Held
151KPut Options Held
1.2K-
Armistice Capital, LLC New York, NY4.42MShares$5.08 Million0.08% of portfolio
-
Black Rock Inc. New York, NY487KShares$560,0120.0% of portfolio
-
Geode Capital Management, LLC Boston, MA438KShares$503,5630.0% of portfolio
-
Ubs Group Ag251KShares$288,8290.0% of portfolio
-
Blair William & CO Chicago, IL250KShares$287,5000.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $32.7M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...